Global OTC Anti-Infective Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Anti-Infective Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Anti-infectives are medicines that work to prevent or treat infections.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
OTC Anti-Infective Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Anti-Infective Products market is projected to reach US$ 16880 million in 2034, increasing from US$ 13320 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Anti-Infective Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sales Channel and Regions Listed in the Report
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Anti-Infective Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Anti-Infective Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Anti-Infective Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Anti-Infective Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sales Channel, Volume and Revenue analysis of Each Sales Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Anti-Infective Products introduction, etc. OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Anti-Infective Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Anti-infective drugs used for the purpose of killing or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host. Infection causing micro-organisms include bacteria, viruses, fungi, viroids, and macro parasites.
OTC Anti-Infective Products report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Anti-Infective Products market is projected to reach US$ 16880 million in 2034, increasing from US$ 13320 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Global core OTC anti-infective products manufacturers include Teva, MYLAN and NOVARTIS etc. The Top 3 companies hold a share above 10%. Asia-Pacific is the largest market, with a share about 38%, followed by North America and Europe with the share about 30% and 20%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Anti-Infective Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Sales Channel and Regions Listed in the Report
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
Segment by Sales Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Anti-Infective Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of OTC Anti-Infective Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the OTC Anti-Infective Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of OTC Anti-Infective Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Sales Channel, Volume and Revenue analysis of Each Sales Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, OTC Anti-Infective Products introduction, etc. OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of OTC Anti-Infective Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices